Microdosimetry is an important tool for assessing energy deposition distributions from ionizing radiation at cellular and cellular nucleus scales. It has served as an input parameter for multiple common mathematical models, including evaluation of relative biological effectiveness (RBE) of carbon ion therapy. The most common detector used for microdosimetry is the tissue-equivalent proportional counter (TEPC). Although it is widely applied, TEPC has various inherent uncertainties. Therefore, this work quantified the magnitude of TEPC measurement uncertainties and their impact on RBE estimates for therapeutic carbon beams. Microdosimetric spectra and frequency-, dose-, and saturation-corrected dose-mean lineal energy (****) were calculated using the Monte Carlo toolkit Geant4 for five monoenergetic and three spread-out Bragg peak carbon beams in water at every millimeter along the central beam axis. We simulated the following influences on these spectra from eight sources of uncertainty: wall effects, pulse pile-up, electronics, gas pressure, W-value, gain instability, low energy cut-off, and counting statistics. Statistic uncertainty was quantified as the standard deviation of perturbed values for each source. Bias was quantified as the difference between default lineal energy values and the mean of perturbed values for each systematic source. Uncertainties were propagated to RBE using the modified microdosimetric kinetic model (MKM). Variance introduced by statistic sources in and averaged 3.8% and 3.4%, respectively, and 1.5% in across beam depths and energies. Bias averaged 6.2% and 7.3% in and and 4.8% in These uncertainties corresponded to 1.2 ± 0.9% on average in RBE MKM . The largest contributors to variance and bias were pulse pile-up and wall effects. This study established an error budget for microdosimetric carbon measurements by quantifying uncertainty inherent to TEPC measurements. It is necessary to understand how robust the measurement of RBE model input parameters are against this uncertainty in order to verify clinical model implementation.
In magnetic nanoparticle hyperthermia therapy and research, accurate sensors are required to monitor the temperature and, potentially, other parameters such as magnetic field or mechanical stress. Conducting materials undergo eddy current heating in an alternating magnetic field (AMF), which is problematic. However, eddy current heating is strongly dependent on the size and geometry of the conducting part, thus micro- or nano-scale electronics are a promising option. This paper reports calculations and measurements of self-heating in thin wires (thermocouples) and patterned thin films (resistive thermometers) in an AMF. Thin (40 gauge) type E thermocouples show no significant self-heating compared with the background, while type K and T thermocouples and thicker (20 gauge) type E, K, and T thermocouples show significant self-heating. A thin film resistive thermometer shows no significant self-heating compared with the background when placed parallel to the field, but has significant self-heating when placed perpendicular. Thus, electronic measurements in an AMF are feasible with appropriate material properties and geometries, and are a promising possibility for future investigations in magnetic nanoparticle hyperthermia.
Microdosimetric distributions are important to accurately describe the biological impact of ionizing radiation, particularly in ion therapy. The computational demands of track structure simulations, a gold standard for modeling microscopic energy deposition, limit their practicality for large-scale or clinical applications. The analytical microdosimetric function (AMF) is a computationally efficient function that reproduces track structure simulation results. First introduced in the particle and heavy ion transport code system Monte Carlo code in 2006 and updated in 2023, the AMF offers a promising alternative for calculating microdosimetric spectra. This study implements the AMF within the Geant4-based Tool for Particle Therapy (TOPAS) platform, enabling efficient calculation of microdosimetric spectra and radiobiological metrics, including dose-mean lineal energy ( ) and relative biological effectiveness (RBE) using clinically relevant models, including the modified microdosimetric kinetic model and Mayo Clinic Florida MKM. Using OpenTOPAS (v4.0.0), the AMF extension was benchmarked against TOPAS-nBio track structure simulations for ions relevant to radiotherapy and space applications (1H, 4He, 7Li, 12C, 16O, 20Ne, 40Ar, 56Fe). AMF results were further compared with TOPAS-nBio at different depths within the mixed radiation field of a carbon spread-out Bragg peak (SOBP). The AMF extension demonstrated reasonable agreement with TOPAS-nBio track structure simulations for most ions and energies. Microdosimetric spectra and derived metrics, and RBE, showed average discrepancies under 10% for most cases. Deviations were largely attributed to differences in Monte Carlo stopping power models and ionization cross-sections. In an SOBP, the RBE calculated using TOPAS-nBio and AMF consistently agreed within 5%. Additionally, the AMF achieved significant computational efficiency, reducing simulation times by over 98% compared to TOPAS-nBio at discrete depths in an SOBP. The AMF extension in TOPAS provides a computationally efficient alternative to track structure simulations for microdosimetric analysis and RBE modeling. Its integration with advanced RBE models enables rapid, accurate calculations critical for particle therapy research and clinical treatment planning.
Microdosimetry plays a critical role in particle therapy by quantifying energy deposition within microscopic domains to assess biological effects. This study evaluates the influence of different microdosimetric functions (MFs) and domain geometries (DGs) on relative biological effectiveness (RBE) predictions in carbon ion radiotherapy. Specifically, we compare the analytical microdosimetric function (AMF), calculated for spherical domains and implemented in PHITS, with the Kiefer–Chatterjee (KC) track structure model, which is conventionally applied to cylindrical geometries. To enable a direct comparison, we also introduce a novel implementation of the KC model for spherical domains. Using both models, specific energy distributions were calculated across a range of domain sizes and geometries. These distributions were input into the modified microdosimetric kinetic model (mMKM) to calculate RBE for the HSG cell line and compared against published in vitro data. The results show that both microdosimetric function and domain geometry significantly affect microdosimetric spectra and the resulting RBE, with deviations exceeding 10% when fixed mMKM parameters are used. Parameter optimization within the mMKM enables alignment across models. Our findings emphasize that microdosimetric function and domain geometry selection must be explicitly accounted for in microdosimetry-based RBE modeling, and that model parameters must be tuned accordingly to ensure consistent and biologically accurate predictions.
Ion radiotherapy requires accurate relative biological effectiveness (RBE) calculations to account for the markedly different biological effects of ions compared to photons. Microdosimetric RBE models rely on descriptions of the energy deposition at the microscopic scale, either through radial dose distributions (RDDs) or microdosimetric probability density distributions. While RDD approaches focus on the theoretical description of the energy deposition around the ion track, microdosimetric distributions offer the advantage of being experimentally measurable, which is crucial for quality assurance programs. As the results of microdosimetric RBE models depend on whether RDD or microdosimetric distributions are used, the model parameters are not interchangeable between these approaches. This study presents and validates a method to reproduce the published reference biological and clinical dose calculations at NIRS-QST for only carbon ion radiotherapy by using the modified microdosimetric kinetic model (MKM) alongside microdosimetric distributions instead of the reference RDD approach. To achieve this, Monte Carlo simulations were performed to estimate the variation of the radiation quality within and outside the field of pristine and spread-out Bragg peaks. By appropriately optimizing the modified MKM parameters for microdosimetric distributions assessed within water spheres, we successfully reproduced the results of calculations using the reference NIRS-QST RDD, generally within 2%.
Objective . This study characterized optically-stimulated luminescent dosimeter (OSLD) nanoDots for use in a therapeutic carbon beam using the Imaging and Radiation Oncology Core (IROC) framework for remote output verification. Approach . The absorbed dose correction factors for OSLD (fading, linearity, beam quality, angularity, and depletion), as defined by AAPM TG 191, were characterized for carbon beams. For the various correction factors, the effect of linear energy transfer (LET) was examined by characterizing in both a low and high LET setting. Main results . Fading was not statistically different between reference photons and carbon, nor between low and high LET beams; thus, the standard IROC-defined exponential function could be used to characterize fading. Dose linearity was characterized with a linear fit; while low and high LET carbon linearity was different, these differences were small and could be rolled into the uncertainty budget if using a single linearity correction. A linear fit between beam quality and dose-averaged LET was determined. The OSLD response at various angles of incidence was not statistically different, thus a correction factor need not be applied. There was a difference in depletion between low and high LET irradiations in a primary carbon beam, but this difference was small over the standard five readings. The largest uncertainty associated with the use of OSLDs in carbon was because of the kQ correction factor, with an uncertainty of 6.0%. The overall uncertainty budget was 6.3% for standard irradiation conditions. Significance . OSLD nanoDot response was characterized in a therapeutic carbon beam. The uncertainty was larger than for traditional photon applications. These findings enable the use of OSLDs for carbon absorbed dose measurements, but with less accuracy than conventional OSLD audit programs.